If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
How do you treat a Trulicity® (dulaglutide) overdose?
In the event of dulaglutide overdose, appropriate supportive care should be initiated according to the patient’s clinical signs and symptoms.
See important safety information, including boxed warning, in the attached prescribing information.
Overdoses of dulaglutide have been reported in clinical studies.1
Effects of overdose with dulaglutide in clinical studies have primarily included mild or moderate gastrointestinal events (eg, nausea, vomiting) and non-severe hypoglycemia.1
In the event of an overdose, appropriate supportive treatment (including frequent plasma glucose monitoring) should be initiated according to the patient’s clinical signs and symptoms.1
Enclosed Prescribing Information
1Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2022.
Date of Last Review: April 10, 2023